NYR 26.4% 11.0¢ nyrada inc.

Ann: Brain Injury Program GLP Studies Further Update, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,246 Posts.
    lightbulb Created with Sketch. 356
    I thought the Cap was $10 mil

    You lost $4 mil somewhere Roch?

    Again, you prove you are the least informed poster on HotCopper.

    GLP studies are the square root of sweet FA to do with drug safety.

    They are testing the lab conditions - absolutely zero to do with any drug.

    This is how we know you are Roch (besides the identical grammar) - there cannot be two people as completely wrong about everything as you are on HotCopper.
    It's impossible.

    https://hotcopper.com.au/data/attachments/6372/6372351-43d055b8eb55c2a967705f5b8922b9dd.jpg


    Fully funded Stage 1 - Nyrada got $6 million USD hidden away somewhere?

    People on here were asking you for advice................

    Here's some - there's a CR coming.

    CEO James is hosting a Webinar next week on non dilutive funding after phase 1 completion

    You haven't even lodged an application yet, let alone announced a base for the trial. Phase 1 is 2 yrs away at the earliest. That's if you find some money in the meantime.....

    Last edited by Hawk70: 10/08/24
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.